Posts Feed
Comments Feed

Archive for the 'Crohn' Category

Remicade(R) (Infliximab) Is More Likely To Induce Steroid-Free Remission And Mucosal Healing Compared With Azathioprine

Oct 26th 2008Drug InformationCrohn

Data presented today at the United European Gastroenterology Week Congress (UEGW) show that a significantly greater proportion of patients with moderate to severe Crohn’s disease experienced steroid-free remission and mucosal healing when receiving Remicade(R) (infliximab), either in combination with azathioprine or as monotherapy, compared to patients receiving azathioprine alone.

More: continued here

No Comments »

CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation In Crohn’s Disease Patients

Oct 13th 2008Drug InformationCrohn

Data from two studies presented this week by UCB at the American College of Gastroenterology (ACG) Annual Meeting demonstrate that CIMZIA(R) (certolizumab pegol) - the only PEGylated anti-TNF alpha (Tumor Necrosis Factor alpha) - provides sustained improvement in symptoms with stable dosing for adult patients suffering from moderate to severe Crohn’s disease (CD).

More: continued here

No Comments »

New Findings Show Efficacy Of REMICADE(R) Compared With Azathioprine In Treatment Of Crohn’s Disease According To First-of-its Kind Study

Oct 13th 2008Drug InformationCrohn

Data presented for the first time from the Phase 3b Study of Patients with Crohn’s Disease Naive to Immunomodulators and Biologic Therapy (SONIC) may provide new insights into the approach to care of patients with moderate to severe Crohn’s disease.

More: continued here

No Comments »

« Prev - Next »

1